<ul data-eligibleForWebStory="false"><li>BC Investments IV Ltd. sold 45 lakh shares worth Rs 562.7 crore in Emcure Pharmaceuticals Ltd. through a block deal on the National Stock Exchange.</li><li>The public shareholder sold their 2.37% stake for Rs 1,250.44 apiece with Kotak Securities as the book runners for the deal.</li><li>Shares of Emcure closed 2.15% lower at Rs 1,252.30 apiece on the NSE. Analysts recommend a 'buy' or 'hold' with an average 12-month price target suggesting a potential downside of 16.5%.</li><li>The stock has shown a 24.24% rise in the last 12 months but has declined by 13.46% year-to-date.</li></ul>

Emcure Pharmaceuticals Bulk Deal: BC Investments Offloads Stake For Rs 563 Crore

Discover more